In children with juvenile rheumatoid arthritis who show continued response to etanercept, the drug can be given safely for at least 8 years. Traditional treatment for juvenile rheumatoid arthritis ...

Alston & Bird on behalf of a rival pharma company alleges Amgen prevented would-be competitors from entering the U.S. product market for etanercept in violation of the Sherman Act. Representing ...

Etanercept is a biologic medicine used to treat a range of disabling inflammatory diseases. Sandoz alleges that Amgen blocked competition from more cost-effective biosimilar competitors ...

Sandoz filed an antitrust lawsuit in the US District Court for the Eastern District of Virginia against Amgen for extending and entrenching the dominant market position of Enbrel (etanercept), a ...

Etanercept is a biologic medicine used to treat a range of disabling inflammatory diseases. Sandoz alleges that Amgen blocked competition from more cost-effective biosimilar competitors ...

Etanercept is a biologic medicine used to treat a range of disabling inflammatory diseases. Sandoz alleges that Amgen blocked competition from more cost-effective biosimilar competitors, including ...